Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Novel Insights and Therapeutics in Multiple Sclerosis.
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
The potential of LINGO-1 as a therapeutic target for essential tremor.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy.
Evidence of Oxidative Stress in Very Long Chain Fatty Acid - Treated Oligodendrocytes and Potentialization of Ros Production Using Rna Interference Directed Knockdown of Abcd1 and Acox1 Peroxisomal Proteins.
The putative acceleration of optic neuritis when combined with chronic hepatitis B.
Cognitive dysfunction in pediatric multiple sclerosis.
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats.
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme.
ATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry Study.
CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
Measurement characteristics and clinical utility of the Brief Pain Inventory-Short Form for individuals with multiple sclerosis.
Pages
« first
‹ previous
…
659
660
661
662
663
664
665
666
667
…
next ›
last »